• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鞘脂代谢改变损害线粒体功能:从戈谢病和法布里病中吸取的教训。

Altered Sphingolipids Metabolism Damaged Mitochondrial Functions: Lessons Learned From Gaucher and Fabry Diseases.

作者信息

Ivanova Margarita

机构信息

Lysosomal and Rare Disorders Research and Treatment Center, Faitfax, VA 22030, USA.

出版信息

J Clin Med. 2020 Apr 14;9(4):1116. doi: 10.3390/jcm9041116.

DOI:10.3390/jcm9041116
PMID:32295103
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7230936/
Abstract

Sphingolipids represent a class of bioactive lipids that modulate the biophysical properties of biological membranes and play a critical role in cell signal transduction. Multiple studies have demonstrated that sphingolipids control crucial cellular functions such as the cell cycle, senescence, autophagy, apoptosis, cell migration, and inflammation. Sphingolipid metabolism is highly compartmentalized within the subcellular locations. However, the majority of steps of sphingolipids metabolism occur in lysosomes. Altered sphingolipid metabolism with an accumulation of undigested substrates in lysosomes due to lysosomal enzyme deficiency is linked to lysosomal storage disorders (LSD). Trapping of sphingolipids and their metabolites in the lysosomes inhibits lipid recycling, which has a direct effect on the lipid composition of cellular membranes, including the inner mitochondrial membrane. Additionally, lysosomes are not only the house of digestive enzymes, but are also responsible for trafficking organelles, sensing nutrients, and repairing mitochondria. However, lysosomal abnormalities lead to alteration of autophagy and disturb the energy balance and mitochondrial function. In this review, an overview of mitochondrial function in cells with altered sphingolipid metabolism will be discussed focusing on the two most common sphingolipid disorders, Gaucher and Fabry diseases. The review highlights the status of mitochondrial energy metabolism and the regulation of mitochondria-autophagy-lysosome crosstalk.

摘要

鞘脂是一类生物活性脂质,可调节生物膜的生物物理特性,并在细胞信号转导中发挥关键作用。多项研究表明,鞘脂可控制关键的细胞功能,如细胞周期、衰老、自噬、凋亡、细胞迁移和炎症。鞘脂代谢在亚细胞位置高度分区。然而,鞘脂代谢的大部分步骤发生在溶酶体中。由于溶酶体酶缺乏导致溶酶体中未消化底物积累,从而改变鞘脂代谢,这与溶酶体贮积症(LSD)有关。鞘脂及其代谢产物被困在溶酶体中会抑制脂质循环,这对细胞膜(包括线粒体内膜)的脂质组成有直接影响。此外,溶酶体不仅是消化酶的储存场所,还负责细胞器运输、感知营养物质和修复线粒体。然而,溶酶体异常会导致自噬改变,并扰乱能量平衡和线粒体功能。在本综述中,将讨论鞘脂代谢改变的细胞中线粒体功能的概况,重点关注两种最常见的鞘脂疾病,戈谢病和法布里病。本综述强调了线粒体能量代谢的状态以及线粒体-自噬-溶酶体相互作用的调节。

相似文献

1
Altered Sphingolipids Metabolism Damaged Mitochondrial Functions: Lessons Learned From Gaucher and Fabry Diseases.鞘脂代谢改变损害线粒体功能:从戈谢病和法布里病中吸取的教训。
J Clin Med. 2020 Apr 14;9(4):1116. doi: 10.3390/jcm9041116.
2
Impaired autophagic and mitochondrial functions are partially restored by ERT in Gaucher and Fabry diseases.在戈谢氏病和法布里病中,ERT 部分恢复了自噬和线粒体功能的障碍。
PLoS One. 2019 Jan 11;14(1):e0210617. doi: 10.1371/journal.pone.0210617. eCollection 2019.
3
The Link between Gaucher Disease and Parkinson's Disease Sheds Light on Old and Novel Disorders of Sphingolipid Metabolism.戈谢病与帕金森病之间的关联为鞘脂代谢的旧疾与新疾提供了新的认识。
Int J Mol Sci. 2019 Jul 5;20(13):3304. doi: 10.3390/ijms20133304.
4
Sphingolipids in mitochondria.线粒体中的神经鞘脂。
Biochim Biophys Acta Mol Cell Biol Lipids. 2017 Jan;1862(1):56-68. doi: 10.1016/j.bbalip.2016.09.019. Epub 2016 Sep 30.
5
Regulation of the lysosome by sphingolipids: Potential role in aging.鞘脂类物质对溶酶体的调节:在衰老中的潜在作用。
J Biol Chem. 2022 Jul;298(7):102118. doi: 10.1016/j.jbc.2022.102118. Epub 2022 Jun 9.
6
Sphingolipids as Regulators of Autophagy and Endocytic Trafficking.鞘脂作为自噬和内吞运输的调节剂。
Adv Cancer Res. 2018;140:27-60. doi: 10.1016/bs.acr.2018.04.008. Epub 2018 May 22.
7
Molecular facets of sphingolipids: mediators of diseases.鞘脂的分子层面:疾病介质
Biotechnol J. 2009 Jul;4(7):1028-41. doi: 10.1002/biot.200800322.
8
Sphingolipids and mitochondrial apoptosis.鞘脂与线粒体凋亡
J Bioenerg Biomembr. 2016 Apr;48(2):153-68. doi: 10.1007/s10863-015-9602-3.
9
Sphingolipids and lysosomal pathologies.鞘脂与溶酶体疾病。
Biochim Biophys Acta. 2014 May;1841(5):799-810. doi: 10.1016/j.bbalip.2013.10.015. Epub 2013 Oct 31.
10
When lipid homeostasis runs havoc: Lipotoxicity links lysosomal dysfunction to autophagy.当脂质稳态失衡时:脂毒性将溶酶体功能障碍与自噬联系起来。
Matrix Biol. 2021 Jun;100-101:99-117. doi: 10.1016/j.matbio.2020.11.005. Epub 2020 Dec 5.

引用本文的文献

1
Sphingolipids and Male Reproductive Health: A Narrative Review of Their Roles in Spermatogenesis, Fertility, and Dysfunction.鞘脂与男性生殖健康:关于其在精子发生、生育能力及功能障碍中作用的叙述性综述
Reprod Sci. 2025 Jun 12. doi: 10.1007/s43032-025-01898-4.
2
Bioactivity Assessment and Untargeted Metabolomics of the Mediterranean Sea Pen .地中海海笔的生物活性评估与非靶向代谢组学
Mar Drugs. 2025 May 21;23(5):218. doi: 10.3390/md23050218.
3
Sex Differences in Circulating Inflammatory, Immune, and Tissue Growth Markers Associated with Fabry Disease-Related Cardiomyopathy.

本文引用的文献

1
Lysosomes as dynamic regulators of cell and organismal homeostasis.溶酶体作为细胞和整体内稳态的动态调节剂。
Nat Rev Mol Cell Biol. 2020 Feb;21(2):101-118. doi: 10.1038/s41580-019-0185-4. Epub 2019 Nov 25.
2
Pharmacologic properties of high-dose ambroxol in four patients with Gaucher disease and myoclonic epilepsy.高剂量盐酸氨溴索在四名戈谢病伴肌阵挛性癫痫患者中的药理特性。
J Med Genet. 2020 Feb;57(2):124-131. doi: 10.1136/jmedgenet-2019-106132. Epub 2019 Oct 24.
3
Effect of Ambroxol chaperone therapy on Glucosylsphingosine (Lyso-Gb1) levels in two Canadian patients with type 3 Gaucher disease.
与法布里病相关心肌病相关的循环炎症、免疫和组织生长标志物的性别差异。
Cells. 2025 Feb 20;14(5):322. doi: 10.3390/cells14050322.
4
Effects of Current Therapies on Disease Progression in Fabry Disease: A Narrative Review for Better Patient Management in Clinical Practice.当前疗法对法布里病疾病进展的影响:临床实践中改善患者管理的叙述性综述
Adv Ther. 2025 Feb;42(2):597-635. doi: 10.1007/s12325-024-03041-2. Epub 2024 Dec 5.
5
Glycosphingolipids in Cardiovascular Disease: Insights from Molecular Mechanisms and Heart Failure Models.心血管疾病中的糖鞘脂:从分子机制和心力衰竭模型中获得的见解。
Biomolecules. 2024 Oct 8;14(10):1265. doi: 10.3390/biom14101265.
6
2024 Update of the TSOC Expert Consensus of Fabry Disease.《法布里病TSOC专家共识2024年更新》
Acta Cardiol Sin. 2024 Sep;40(5):544-568. doi: 10.6515/ACS.202409_40(5).20240731A.
7
The Heart in Fabry Disease: Mechanisms Beyond Storage and Forthcoming Therapies.法布里病中的心脏:储存之外的机制及未来疗法
Rev Cardiovasc Med. 2022 May 27;23(6):196. doi: 10.31083/j.rcm2306196. eCollection 2022 Jun.
8
Inflammation and Exosomes in Fabry Disease Pathogenesis.炎症与法布雷病发病机制中的外泌体
Cells. 2024 Apr 9;13(8):654. doi: 10.3390/cells13080654.
9
Small fibre neuropathy in Fabry disease: a human-derived neuronal disease model and pilot data.法布里病中的小纤维神经病变:一种源自人类的神经元疾病模型及初步数据。
Brain Commun. 2024 Apr 3;6(2):fcae095. doi: 10.1093/braincomms/fcae095. eCollection 2024.
10
Plasma metabolomic markers underlying skeletal muscle mitochondrial function relationships with cognition and motor function.骨骼肌线粒体功能与认知和运动功能关系的血浆代谢组学标志物。
Age Ageing. 2024 Apr 1;53(4). doi: 10.1093/ageing/afae079.
氨溴索伴侣疗法对两名加拿大3型戈谢病患者葡萄糖神经酰胺(溶血神经酰胺1)水平的影响。
Mol Genet Metab Rep. 2019 May 17;20:100476. doi: 10.1016/j.ymgmr.2019.100476. eCollection 2019 Sep.
4
A Human Stem Cell Model of Fabry Disease Implicates LIMP-2 Accumulation in Cardiomyocyte Pathology.人源法布雷病干细胞模型提示溶酶体关联膜蛋白 2 蓄积在心肌病理中的作用。
Stem Cell Reports. 2019 Aug 13;13(2):380-393. doi: 10.1016/j.stemcr.2019.07.004. Epub 2019 Aug 1.
5
Altered immune phenotypes in subjects with Fabry disease and responses to switching from agalsidase alfa to agalsidase beta.法布里病患者的免疫表型改变以及从阿加糖酶α转换为阿加糖酶β后的反应。
Am J Transl Res. 2019 Mar 15;11(3):1683-1696. eCollection 2019.
6
Generation of -Knockout Human Embryonic Stem Cell Lines to Model Autophagic Dysfunction and Exosome Secretion in Fabry Disease-Associated Hypertrophic Cardiomyopathy.生成 - 敲除人胚胎干细胞系以模拟法布里病相关肥厚型心肌病中的自噬功能障碍和外泌体分泌。
Cells. 2019 Apr 8;8(4):327. doi: 10.3390/cells8040327.
7
Ambroxol as a novel disease-modifying treatment for Parkinson's disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial.氨溴索作为帕金森病痴呆的一种新型疾病修饰治疗方法:一项单中心、随机、双盲、安慰剂对照试验的方案
BMC Neurol. 2019 Feb 9;19(1):20. doi: 10.1186/s12883-019-1252-3.
8
Individualized screening for chaperone activity in Gaucher disease using multiple patient derived primary cell lines.使用多种患者来源的原代细胞系对戈谢病伴侣蛋白活性进行个性化筛查。
Am J Transl Res. 2018 Nov 15;10(11):3750-3761. eCollection 2018.
9
Impaired autophagic and mitochondrial functions are partially restored by ERT in Gaucher and Fabry diseases.在戈谢氏病和法布里病中,ERT 部分恢复了自噬和线粒体功能的障碍。
PLoS One. 2019 Jan 11;14(1):e0210617. doi: 10.1371/journal.pone.0210617. eCollection 2019.
10
Oxidative stress and the altered reaction to it in Fabry disease: A possible target for cardiovascular-renal remodeling?氧化应激与法布里病中对其的改变反应:心血管-肾脏重构的一个可能靶点?
PLoS One. 2018 Sep 27;13(9):e0204618. doi: 10.1371/journal.pone.0204618. eCollection 2018.